|
Q2 FY2026
As of Aug 13, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q1 FY2026
As of Apr 10, 2026
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
|
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| CURRENT ASSETS | ||||||
| Cash | ||||||
| Cash and cash equivalents | ||||||
| Investments at fair value | ||||||
| Accounts receivable, net of allowance | ||||||
| Prepaid expenses | ||||||
| Other current assets | ||||||
| Total current assets | ||||||
| OTHER ASSETS | ||||||
| Property and equipment, net | ||||||
| Right of use assets - operating leases | ||||||
| Patents, net of accumulated amortization of $3,636 and $2,603 | ||||||
| Security deposits | ||||||
| Deferred offering costs | ||||||
| Other assets | ||||||
| Total other assets | ||||||
| TOTAL ASSETS | ||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||
| CURRENT LIABILITIES | ||||||
| Accounts payable | ||||||
| Accrued expenses | ||||||
| Credit card payable | ||||||
| Operating lease liability | ||||||
| Derivative liabilities | ||||||
| Convertible note payable, net of discount and debt issuance costs of $1,842,184, and $3,620,343, respectively | ||||||
| Note payable | ||||||
| Total current liabilities | ||||||
| LONG TERM LIABILITIES | ||||||
| Operating lease liability | ||||||
| Note payables, net of current portion | ||||||
| Total long term liabilities | ||||||
| Total liabilities | ||||||
| STOCKHOLDERS’ EQUITY | ||||||
| Common stock, $0.0002 par value, 200,000,000 authorized, 51,859,347 and 34,213,387 issued and outstanding at June 30, 2026 and December 31, 2025 | ||||||
| Treasury stock, at cost, 19,700 and -0- shares as of September 30, 2025, and December 31, 2024 | ||||||
| Additional paid-in capital | ||||||
| Subscription receivable | ||||||
| Deferred compensation | ||||||
| Accumulated deficit | ||||||
| Total stockholders’ equity | ||||||
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY |
Loading...
